Thu.Jul 04, 2024

article thumbnail

Scientists discover new T cells and genes related to immune disorders

Science Daily: Pharmacology News

Researchers have discovered several rare types of helper T cells that are associated with immune disorders such as multiple sclerosis, rheumatoid arthritis, and even asthma. The discoveries were made possible by a newly developed technology they call ReapTEC. The new T cell atlas is publicly available and should help in the development of new drug therapies for immune-mediated diseases.

Therapies 345
article thumbnail

About 1 in 8 Americans Has Been Diagnosed With Chronic Insomnia

Drugs.com

FRIDAY, July 4, 2024 -- Millions of Americans struggle to fall or stay asleep, a new survey finds. Some struggle more mightily than others: Roughly 12% of Americans polled said they have been diagnosed with chronic insomnia, the American Academy of.

262
262
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The dawn of the Antarctic ice sheets

Science Daily: Pharmacology News

In recent years global warming has left its mark on the Antarctic ice sheets. The 'eternal' ice in Antarctica is melting faster than previously assumed, particularly in West Antarctica more than East Antarctica. The root for this could lie in its formation, as an international research team has now discovered: sediment samples from drill cores combined with complex climate and ice-sheet modelling show that permanent glaciation of Antarctica began around 34 million years ago -- but did not encomp

article thumbnail

Unsafe Neighborhoods Could Drive Up Smoking Rates

Drugs.com

THURSDAY, July 4, 2024 -- It may sound far-fetched, but new research suggests that living in dangerous neighborhoods could trigger an unintended health harm: higher smoking rates among residents. "High levels of neighborhood threat shape.

Research 242
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Which pharmaceutical companies have the most gas dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most gas dosed drugs. For a different perspective, see the most popular dosage types.

More Trending

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 59
article thumbnail

When Bills Become an Issue, Couples Stop Communicating

Drugs.com

FRIDAY, July 4, 2024 -- If you and your partner fall silent when vexing money issues arise, new research suggests you are not alone. A team from Cornell University found that the more stressed people were about their finances, the less likely they.

Research 130
article thumbnail

Aldehyde oxidase-mediated DDI

Metabolite Tales Blog

First-ever identification of an aldehyde oxidase-mediated DDI Inhibition of aldehyde oxidase mediated metabolism of OS1-930 by erlotinib Where metabolic pathways have not been interrogated for drugs in development, unwelcome surprises may arise. Scientists at Pfizer recently uncovered a major role for aldehyde oxidase in the metabolism of quinoline-containing OSI-930, and demonstrated an aldehyde oxidase-mediated DDI (drug-drug interaction) arising from inhibition of the enzyme by erlotinib (Tan

Drugs 52
article thumbnail

CDISC Standards for Biostatistics and Clinical Data Management

ProRelix Research

Collating and integrating data from a myriad of sources especially in global clinical trials requires that the data be in an accurate, reliable, and consistent format. The application of standards […] The post CDISC Standards for Biostatistics and Clinical Data Management appeared first on ProRelix Research.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FlexCards in Salesforce OmniStudio: A Beginner’s Guide

Perficient: Drug Development

Introduction FlexCards in Salesforce OmniStudio are powerful components designed to display data from multiple sources in a visually appealing and customizable manner. They provide a way to consolidate information and present it in a single, unified view, making it easier for users to interact with and understand complex data. Build industry-specific UI components and applications on the Salesforce platform with OmniStudio FlexCards.

52